Approval · Notice of Compliance 33697 · 2024
PAXLOVID: Notice of Compliance 33697
Issued July 24, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33697
- Date
- July 24, 2024
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PAXLOVID | Not yet assigned | — |
Medicinal ingredients
- RITONAVIR 100 MG per TAB
- NIRMATRELVIR 150 MG per TAB